| | Class 2 Device Recall Vitrex |  |
| Date Initiated by Firm | May 08, 2008 |
| Date Posted | August 14, 2008 |
| Recall Status1 |
Terminated 3 on January 22, 2010 |
| Recall Number | Z-2152-2008 |
| Recall Event ID |
48435 |
| Product Classification |
blood gas capillary tubes - Product Code GIO
|
| Product | Vitrex Blood Gas Capillary Tubes, MC0024, REF 189301, 250 pcs, 1,45 x 1,85 x 125 mm app. 200l, Heparinized: 6 IU Na & 9 IU Li/100 l, |
| Code Information |
Part #MC0024, Lot #1112254 |
Recalling Firm/ Manufacturer |
Opti Medical Systems Inc 235 Hembree Park Dr Ste 200 Roswell GA 300765700
|
| For Additional Information Contact | Len Owens 770-510-4444 Ext. 573 |
Manufacturer Reason for Recall | This lot of Heparinized Capillary Tubes contain contaminated lithium heparin. |
FDA Determined Cause 2 | Nonconforming Material/Component |
| Action | Opti Medical sent a Recall Notice, dated May 8, 2008 to all consignees. Consignees were notified via email on/about May 5th thru 7th , 2008. They were instructed to discontinue use of the affected lot and to immediately return all remaining product to OPTI Medical for replacement. |
| Quantity in Commerce | 31750 tubes |
| Distribution | Worldwide Distribution: USA, Puerto Rico, Austria, China, Chile, Cyprus, Great Britain, Japan, Netherlands, and Senegal |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|